Lasix Fiale (Furosemide)

Furosemide acts on the thick ascending limb of the loop of Henle, where it blocks the Na+/K+/2Cl‑ cotransporter. This inhibition prevents reabsorption of sodium, chloride, and potassium, leading to increased excretion of these ions together with water, which reduces extracellular fluid volume.

The specific dose of Lasix Fiale is determined by the prescribing clinician based on the patient’s condition, severity of edema, renal function, and response to therapy. Dosage adjustments are individualized and should follow the prescriber’s instructions.

The safety of Lasix Fiale in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lasix Fiale (furosemide) is a loop diuretic, which is generally more potent than thiazide or potassium‑sparing diuretics for rapid fluid removal. It is preferred in acute settings such as severe edema or hypertensive emergencies, whereas other classes may be used for chronic, milder fluid management.

Lasix Fiale should be stored at 2‑8 °C (refrigerated), protected from light, and must not be frozen or shaken. Maintaining the cold chain preserves the stability and sterility of the injectable solution.

Lasix Fiale is administered by a healthcare professional via intramuscular or intravenous injection. The route, rate of infusion, and volume depend on the clinical situation and the prescriber’s orders.

Serious risks include ototoxicity (potential hearing loss), severe electrolyte imbalances such as hypokalemia or hyponatremia, acute kidney injury, and hypersensitivity reactions. Patients should be monitored closely for these complications, especially during high‑dose or prolonged therapy.

Lasix Fiale is contraindicated in patients with anuria (no urine output) and in those with known hypersensitivity to furosemide or other sulfonamide-derived drugs. Caution is also advised in individuals with severe hepatic impairment or uncontrolled electrolyte disturbances.